A Multicenter, Open-Label, Single-Arm Trial of the Efficacy and Safety of Empagliflozin Treatment for Refractory Diabetes Mellitus with Insulin Resistance (EMPIRE-01) - Hirota, Yushi; Kakei, Yasumasa; Imai, Junta; Katagiri, Hideki; Ebihara, Ken; Wada, Jun; Suzuki, Junichi; Urakami, Tatsuhiko; Omori, Takashi; Ogawa, Wataru (Diabetes therapy, 2024)
Keywords: Blood sugar monitoring; Body fat; Cardiology; Clinical trials; Dextrose; Diabetes; Diabetes therapy; Drug dosages; Drug therapy; Endocrinology; Genes; Glucose; Glycosylated hemoglobin; Hypoglycemic agents; Insulin resistance; Internal Medicine; Medical colleges; Medicine; Medicine & Public Health; Metabolism; Original Research; Pharmaceutical industry; Statistical analysis; Type 2 diabetes; Weight control; Japan; Empagliflozin; Genetic insulin resistance syndrome; Type A insulin resistance syndrome; Lipoatrophic diabetes; SGLT2 inhibitor; Type B insulin resistance syndrome